Report Detail
Global Chronic Idiopathic Constipation (CIC) Drugs Market Research Report 2019
- RnM3116491 |
- 31 July, 2020 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Chronic Idiopathic Constipation (CIC) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Idiopathic Constipation (CIC) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Chronic Idiopathic Constipation (CIC) Drugs market is segmented into
Lubiprostone
Linaclotide
Others
Segment by Application, the Chronic Idiopathic Constipation (CIC) Drugs market is segmented into
Hospitals & Clinics
Ambulatory Surgical Centres
Long Term Care Centres
Others
Regional and Country-level Analysis
The Chronic Idiopathic Constipation (CIC) Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Chronic Idiopathic Constipation (CIC) Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Chronic Idiopathic Constipation (CIC) Drugs Market Share Analysis
Chronic Idiopathic Constipation (CIC) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Chronic Idiopathic Constipation (CIC) Drugs business, the date to enter into the Chronic Idiopathic Constipation (CIC) Drugs market, Chronic Idiopathic Constipation (CIC) Drugs product introduction, recent developments, etc.
The major vendors covered:
Actavis
Chugai Pharmaceutical
Ferring International Center
Synergy Pharmaceuticals
Pfizer
GlaxoSmithKline
Roche Holding
Sanofi
Bayer
Salix Pharmaceuticals
Sucampo Pharmaceuticals
Ironwood Pharmaceuticals
Progenics Pharmaceuticals
1 Study Coverage
- 1.1 Chronic Idiopathic Constipation (CIC) Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate by Type
- 1.4.2 Lubiprostone
- 1.4.3 Linaclotide
- 1.4.4 Others
- 1.5 Market by Application
- 1.5.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate by Application
- 1.5.2 Hospitals & Clinics
- 1.5.3 Ambulatory Surgical Centres
- 1.5.4 Long Term Care Centres
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size, Estimates and Forecasts
- 2.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue 2015-2026
- 2.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales 2015-2026
- 2.2 Global Chronic Idiopathic Constipation (CIC) Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Chronic Idiopathic Constipation (CIC) Drugs Competitor Landscape by Players
- 3.1 Chronic Idiopathic Constipation (CIC) Drugs Sales by Manufacturers
- 3.1.1 Chronic Idiopathic Constipation (CIC) Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Chronic Idiopathic Constipation (CIC) Drugs Revenue by Manufacturers
- 3.2.1 Chronic Idiopathic Constipation (CIC) Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Chronic Idiopathic Constipation (CIC) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Chronic Idiopathic Constipation (CIC) Drugs Revenue in 2019
- 3.2.5 Global Chronic Idiopathic Constipation (CIC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Chronic Idiopathic Constipation (CIC) Drugs Price by Manufacturers
- 3.4 Chronic Idiopathic Constipation (CIC) Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Chronic Idiopathic Constipation (CIC) Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Chronic Idiopathic Constipation (CIC) Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2015-2020)
- 4.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2015-2020)
- 4.1.3 Chronic Idiopathic Constipation (CIC) Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Chronic Idiopathic Constipation (CIC) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Chronic Idiopathic Constipation (CIC) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2015-2020)
- 5.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2015-2020)
- 5.1.3 Chronic Idiopathic Constipation (CIC) Drugs Price by Application (2015-2020)
- 5.2 Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Chronic Idiopathic Constipation (CIC) Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Chronic Idiopathic Constipation (CIC) Drugs by Country
- 6.1.1 North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country
- 6.1.2 North America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Type
- 6.3 North America Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Chronic Idiopathic Constipation (CIC) Drugs by Country
- 7.1.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Country
- 7.1.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Type
- 7.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs by Region
- 8.1.1 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Region
- 8.1.2 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Chronic Idiopathic Constipation (CIC) Drugs by Country
- 9.1.1 Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country
- 9.1.2 Latin America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Type
- 9.3 Central & South America Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs by Country
- 10.1.1 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Country
- 10.1.2 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 Actavis
- 11.1.1 Actavis Corporation Information
- 11.1.2 Actavis Description and Business Overview
- 11.1.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Actavis Chronic Idiopathic Constipation (CIC) Drugs Products Offered
- 11.1.5 Actavis Related Developments
- 11.2 Chugai Pharmaceutical
- 11.2.1 Chugai Pharmaceutical Corporation Information
- 11.2.2 Chugai Pharmaceutical Description and Business Overview
- 11.2.3 Chugai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Products Offered
- 11.2.5 Chugai Pharmaceutical Related Developments
- 11.3 Ferring International Center
- 11.3.1 Ferring International Center Corporation Information
- 11.3.2 Ferring International Center Description and Business Overview
- 11.3.3 Ferring International Center Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Products Offered
- 11.3.5 Ferring International Center Related Developments
- 11.4 Synergy Pharmaceuticals
- 11.4.1 Synergy Pharmaceuticals Corporation Information
- 11.4.2 Synergy Pharmaceuticals Description and Business Overview
- 11.4.3 Synergy Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Products Offered
- 11.4.5 Synergy Pharmaceuticals Related Developments
- 11.5 Pfizer
- 11.5.1 Pfizer Corporation Information
- 11.5.2 Pfizer Description and Business Overview
- 11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Pfizer Chronic Idiopathic Constipation (CIC) Drugs Products Offered
- 11.5.5 Pfizer Related Developments
- 11.6 GlaxoSmithKline
- 11.6.1 GlaxoSmithKline Corporation Information
- 11.6.2 GlaxoSmithKline Description and Business Overview
- 11.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Products Offered
- 11.6.5 GlaxoSmithKline Related Developments
- 11.7 Roche Holding
- 11.7.1 Roche Holding Corporation Information
- 11.7.2 Roche Holding Description and Business Overview
- 11.7.3 Roche Holding Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Products Offered
- 11.7.5 Roche Holding Related Developments
- 11.8 Sanofi
- 11.8.1 Sanofi Corporation Information
- 11.8.2 Sanofi Description and Business Overview
- 11.8.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Sanofi Chronic Idiopathic Constipation (CIC) Drugs Products Offered
- 11.8.5 Sanofi Related Developments
- 11.9 Bayer
- 11.9.1 Bayer Corporation Information
- 11.9.2 Bayer Description and Business Overview
- 11.9.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Bayer Chronic Idiopathic Constipation (CIC) Drugs Products Offered
- 11.9.5 Bayer Related Developments
- 11.10 Salix Pharmaceuticals
- 11.10.1 Salix Pharmaceuticals Corporation Information
- 11.10.2 Salix Pharmaceuticals Description and Business Overview
- 11.10.3 Salix Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Products Offered
- 11.10.5 Salix Pharmaceuticals Related Developments
- 11.1 Actavis
- 11.1.1 Actavis Corporation Information
- 11.1.2 Actavis Description and Business Overview
- 11.1.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Actavis Chronic Idiopathic Constipation (CIC) Drugs Products Offered
- 11.1.5 Actavis Related Developments
- 11.12 Ironwood Pharmaceuticals
- 11.12.1 Ironwood Pharmaceuticals Corporation Information
- 11.12.2 Ironwood Pharmaceuticals Description and Business Overview
- 11.12.3 Ironwood Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Ironwood Pharmaceuticals Products Offered
- 11.12.5 Ironwood Pharmaceuticals Related Developments
- 11.13 Progenics Pharmaceuticals
- 11.13.1 Progenics Pharmaceuticals Corporation Information
- 11.13.2 Progenics Pharmaceuticals Description and Business Overview
- 11.13.3 Progenics Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Progenics Pharmaceuticals Products Offered
- 11.13.5 Progenics Pharmaceuticals Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Chronic Idiopathic Constipation (CIC) Drugs Market Estimates and Projections by Region
- 12.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Chronic Idiopathic Constipation (CIC) Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Chronic Idiopathic Constipation (CIC) Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Chronic Idiopathic Constipation (CIC) Drugs . Industry analysis & Market Report on Chronic Idiopathic Constipation (CIC) Drugs is a syndicated market report, published as Global Chronic Idiopathic Constipation (CIC) Drugs Market Research Report 2019. It is complete Research Study and Industry Analysis of Chronic Idiopathic Constipation (CIC) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
